Arcutis Biotherapeutics
NASDAQ: ARQTWestlake Village, US · Founded 2016 · Delaware corporation · 3 known investors
Founders & leadership
AA
Alexander AsamNamed on SEC filing
RS
TF
Todd Franklin WatanabeNamed on SEC filing
Board
PH
DE
JS
Jonathan SilversteinBoard director
BC
Investors · 3
Reported raises · per SEC filings
Form D private placements$94.5M disclosed across 1 round · 2019
▶$94.5MraisedOct 2019 · 16 investors · BiotechnologyRule 506(b)
▶$94.5MraisedOct 2019 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander AsamDirector
- Patrick HeronDirector
- Daniel EstesDirector
- Ricky SunDirector
- Jonathan SilversteinDirector
- Bhaskar ChaudhuriDirector
- Todd Franklin WatanabeExecutive Officer, Director
- Offering amount
- $94.5M
- Amount sold
- $94.5M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Arcutis Biotherapeutics (ARQT) Could Be 28% Undervalued As Profit And Guidance Improve - Simply Wall St Newssimplywall.st · Aug 2026Should Arcutis Biotherapeutics’ (ARQT) Strong Q2 and Higher 2026 Sales Outlook Prompt Investor Action? - Simply Wall St Newssimplywall.st · Aug 2026Frequently asked questions
- Who are Arcutis Biotherapeutics's investors?
- Arcutis Biotherapeutics's investors include Bain Capital Life Sciences, RA Capital, Frazier Life Sciences.
- How much funding has Arcutis Biotherapeutics raised?
- Arcutis Biotherapeutics has disclosed $94.5M raised across 1 round.
- Where is Arcutis Biotherapeutics headquartered?
- Arcutis Biotherapeutics is headquartered in Westlake Village, US.